| JOURNAL HOME | CME HOME | THIS MONTH | PAST ISSUES | ETOC | COLLECTIONS |
| AUTHORS | REVIEWERS | EDITORIAL BOARD | FEEDBACK | RSS | HELP |
| ||||||||||||||
| ||||||||||||||
|
|
|
|
||||||||||||
|
||||||||||||||
Department of Anaesthesia, Monash Medical Centre, and Department of Anaesthesia, Monash University, Victoria, Australia
Address correspondence and reprint requests to Adam P. Tucker, MB, ChB, FANZCA, Department of Anaesthesia, Monash Medical Centre, 246 Clayton Rd., Victoria 3168, Australia. Address e-mail to research{at}southernhealth.org.au
Despite conflicting evidence regarding the safety of intrathecal midazolam from animal investigations, its clinical use is increasing. We investigated the potential of intrathecal midazolam to produce symptomatology suggestive of neurological damage. This study compared two cohorts of patients who received intrathecal anesthesia with or without intrathecal midazolam (2 mg). Eighteen risk factors were evaluated with respect to symptoms representing potential neurological complications. The definitions of these symptoms were made wide to maximize the chance of counting patients with neurological sequelae after intrathecal injections. Eleven-hundred patients were followed up prospectively during the first postoperative week by a hospital chart review and 1 mo later by a mailed questionnaire. Symptoms suggestive of neurological impairment, including motor or sensory changes and bladder or bowel dysfunction, were investigated. Intrathecal midazolam was not associated with an increased risk of neurologic symptoms. In contrast, neurologic symptoms were found to be increased by age >70 yr (relative risk, 8.72) and the occurrence of a blood-stained spinal tap (relative risk, 8.07). The administration of intrathecal midazolam, 2 mg, did not increase the occurrence of neurologic or urologic symptoms, as suggested by some preclinical animal experimentation.
IMPLICATIONS: Intrathecal midazolam provides segmental analgesia, but conflicting animal studies have cast doubts on its safety. This investigation studied the effect of intrathecal midazolam by observing two cohorts of patients. In clinical practice, intrathecal midazolam (2 mg) did not increase adverse neurological symptoms compared with conventional therapies.
This article has been cited by other articles:
|
|
 |
|
  M. A. Duncan Labour pains Can Fam Physician, January 1, 2008; 54(1): 28 - 29. [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Shafer Anesthesia & Analgesia's Policy on Off-Label Drug Administration in Clinical Trials Anesth. Analg., July 1, 2007; 105(1): 13 - 15. [Full Text] [PDF]
|
|
|
|
|
|
J. P. Rathmell, T. R. Lair, and B. Nauman The Role of Intrathecal Drugs in the Treatment of Acute Pain Anesth. Analg., November 1, 2005; 101(5S_Suppl): S30 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Jarbo, Y. K. Batra, and N. B. Panda Brachial plexus block with midazolam and bupivacaine improves analgesia: [Le bloc du plexus brachial avec du midazolam et de la bupivacaine ameliore l'analgesie] Can J Anesth, October 1, 2005; 52(8): 822 - 826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Lin More on the Dilemma of Intrathecal Midazolam Anesth. Analg., February 1, 2005; 100(2): 604 - 604. [Full Text] [PDF]
|
|
|
|
|
|
A. P. Tucker, J. Mezzatesta, R. Nadeson, and C. S. Goodchild Intrathecal Midazolam: Adverse Effects and Sources of Bias Anesth. Analg., February 1, 2005; 100(2): 605 - 605. [Full Text] [PDF]
|
|
|
|
|
|
G. A. Van Norman, S. K. Palmer, and S. H. Jackson The Ethical Role of Medical Journal Editors Anesth. Analg., February 1, 2005; 100(2): 603 - 604. [Full Text] [PDF]
|
|
|
|
|
|
M. J. Cousins and R. D. Miller Intrathecal Midazolam: An Ethical Editorial Dilemma Anesth. Analg., June 1, 2004; 98(6): 1507 - 1508. [Full Text] [PDF]
|
|
|
|
|
|
T. L. Yaksh and J. W. Allen Preclinical Insights into the Implementation of Intrathecal Midazolam: A Cautionary Tale Anesth. Analg., June 1, 2004; 98(6): 1509 - 1511. [Full Text] [PDF]
|
|
|
|
|
|
A. P. Tucker, J. Mezzatesta, R. Nadeson, and C. S. Goodchild Intrathecal Midazolam II: Combination with Intrathecal Fentanyl for Labor Pain Anesth. Analg., June 1, 2004; 98(6): 1521 - 1527. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Yaksh and J. W. Allen The Use of Intrathecal Midazolam in Humans: A Case Study of Process Anesth. Analg., June 1, 2004; 98(6): 1536 - 1545. [Abstract] [Full Text] [PDF]
|
|
|
